- ISIN
- US25490K3234
- CUSIP
- 25490K323
- Issuer
- Direxion
- Inception Date
- May 28, 2015
- Region
- North America (U.S.)
- Category
- Leveraged Equities
- Leveraged
- 3x
- Index Tracked
- S&P Biotechnology Select Industry Index (300%)
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Multi-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $539M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LABU Performance Chart
Direxion Daily S&P Biotech Bull 3x Shares (LABU) is down 0.8% since the beginning of the year. LABU is currently trading at $158 per share. Investors who bought $1,000 worth of LABU shares 5 years ago would now be looking at an investment worth $132.
Loading charts...
Returns By Period
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has returned -0.77% so far this year and 193.25% over the past 12 months. Over the last ten years, LABU has returned -13.92% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Direxion Daily S&P Biotech Bull 3x Shares
- 1D
- -12.94%
- 1M
- -8.90%
- YTD
- -0.77%
- 6M
- 7.41%
- 1Y
- 193.25%
- 3Y*
- 6.21%
- 5Y*
- -33.29%
- 10Y*
- -13.92%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
LABU Monthly Returns History
Based on dividend-adjusted daily data since May 28, 2015, LABU's average daily return is +0.09%, while the average monthly return is +0.90%. At this rate, an investment would double in approximately 6.4 years.
Historically, 51% of months were positive and 49% were negative. The best month was Apr 2020 with a return of +63.7%, while the worst month was Jan 2016 at -66.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.
On a daily basis, LABU closed higher 51% of trading days. The best single day was Nov 9, 2016 with a return of +33.4%, while the worst single day was Mar 16, 2020 at -33.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.06% | 4.12% | -3.83% | 6.91% | 9.99% | -19.02% | -0.77% | ||||||
| 2025 | 6.31% | -13.96% | -25.84% | -0.56% | -17.05% | 13.61% | 7.38% | 13.48% | 35.14% | 40.00% | 27.17% | -3.86% | 79.17% |
| 2024 | -8.52% | 35.81% | -12.31% | -31.53% | 13.67% | 9.97% | 19.44% | 4.10% | -8.73% | -7.12% | 4.98% | -28.30% | -26.02% |
| 2023 | 18.10% | -21.32% | -25.27% | 13.44% | 12.03% | -5.01% | 2.03% | -18.38% | -22.68% | -28.61% | 41.91% | 58.33% | -13.41% |
| 2022 | -45.81% | -14.97% | -5.55% | -48.05% | -28.50% | 15.81% | 24.18% | 3.70% | -19.24% | 6.13% | 0.94% | -5.86% | -80.36% |
| 2021 | 25.63% | -12.47% | -28.54% | -0.22% | -20.00% | 16.90% | -25.69% | 21.14% | -16.59% | -3.44% | -20.43% | -15.27% | -64.15% |
Benchmark Metrics
Direxion Daily S&P Biotech Bull 3x Shares has an annualized alpha of -20.86%, beta of 3.42, and R2 of 0.39 versus S&P 500 Index. Calculated based on daily prices since May 29, 2015.
- This ETF captured 284.80% of S&P 500 Index gains and 252.29% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.39 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -20.86%
- Beta
- 3.42
- R²
- 0.39
- Upside Capture
- 284.80%
- Downside Capture
- 252.29%
Expense Ratio
LABU has a high expense ratio of 1.12%, indicating above-average management fees.
Return for Risk
Risk / Return Rank
LABU ranks 74 for risk / return — better than 74% of ETFs on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and compare them to S&P 500 Index.
| LABU | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.57 | 2.39 | +0.18 |
Sortino ratioReturn per unit of downside risk | 2.91 | 3.25 | -0.34 |
Omega ratioGain probability vs. loss probability | 1.34 | 1.43 | -0.09 |
Calmar ratioReturn relative to maximum drawdown | 6.34 | 3.11 | +3.22 |
Martin ratioReturn relative to average drawdown | 18.67 | 14.38 | +4.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Direxion Daily S&P Biotech Bull 3x Shares provided a 0.78% dividend yield over the last twelve months, with an annual payout of $1.23 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.23 | $1.34 | $0.31 | $0.42 | $0.00 | $0.00 | $0.00 | $3.26 | $4.22 | $2.65 |
Dividend yield | 0.78% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Monthly Dividends
The table displays the monthly dividend distributions for Direxion Daily S&P Biotech Bull 3x Shares. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.91 | $1.34 |
| 2024 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.31 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.21 | $0.42 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Direxion Daily S&P Biotech Bull 3x Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Direxion Daily S&P Biotech Bull 3x Shares was 99.18%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Direxion Daily S&P Biotech Bull 3x Shares drawdown is 96.50%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.18%Apr 2025 | 9y 8mo | — | 10y 10moJul 2015 - now |
2015 bear market2015 | -20.23%Jul 2015 | 15d | 6d | 21dJun 2015 - Jul 2015 |
2015 pullback2015 | -4.93%Jun 2015 | 3d | 5d | 8dJun 2015 - Jun 2015 |
2015 pullback2015 | -1.91%Jun 2015 | 0s | 1d | 1dJun 2015 - Jun 2015 |
2015 pullback2015 | -0.95%Jun 2015 | 0s | 1d | 1dJun 2015 - Jun 2015 |
Drawdown Indicators
| LABU | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.18% | -56.78% | -42.40% |
Max Drawdown (1Y)Largest decline over 1 year | -30.70% | -9.10% | -21.60% |
Max Drawdown (3Y)Largest decline over 3 years | -78.30% | -18.90% | -59.40% |
Max Drawdown (5Y)Largest decline over 5 years | -97.59% | -25.43% | -72.16% |
Max Drawdown (10Y)Largest decline over 10 years | -98.96% | -33.92% | -65.04% |
Current DrawdownCurrent decline from peak | -96.50% | 0.00% | -96.50% |
Average DrawdownAverage peak-to-trough decline | -81.67% | -10.72% | -70.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.40% | 1.97% | +8.43% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with LABU
Add Direxion Daily S&P Biotech Bull 3x Shares to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LABU